MD Anderson Researchers Present New Findings in Targeted and Combination Therapies at 2021 ASCO Annual Meeting
May 25, 2021
May 25, 2021
HOUSTON, Texas, May 25 (TNSRes) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The results of these studies, which will be presented at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, highlight . . .
Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The results of these studies, which will be presented at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, highlight . . .